Sumitomo Pharma Co., Ltd. (DNPUF)
OTCMKTS · Delayed Price · Currency is USD
8.97
+1.73 (23.90%)
At close: Aug 13, 2025

Sumitomo Pharma Ratios and Metrics

Millions USD. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 20212017 - 2021
Period Ending
Aug '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 2017 - 2021
4,1231,9341,0452,4213,9526,922
Upgrade
Market Cap Growth
167.32%85.01%-56.82%-38.75%-42.91%33.63%
Upgrade
Enterprise Value
6,0893,8643,5272,6044,9958,376
Upgrade
Last Close Price
8.974.762.406.3810.2218.75
Upgrade
PE Ratio
31.4712.26--8.5113.62
Upgrade
PS Ratio
1.430.730.500.580.861.48
Upgrade
PB Ratio
3.381.711.010.790.711.18
Upgrade
P/TBV Ratio
----34.1537.03
Upgrade
P/FCF Ratio
17.6636.19-92.7420.095.91
Upgrade
P/OCF Ratio
14.3817.55-26.9615.365.65
Upgrade
EV/Sales Ratio
2.151.451.700.621.081.80
Upgrade
EV/EBITDA Ratio
15.0415.00--6.1712.04
Upgrade
EV/EBIT Ratio
25.1144.43--10.1217.06
Upgrade
EV/FCF Ratio
26.0772.31-99.7525.397.15
Upgrade
Debt / Equity Ratio
1.761.852.740.850.420.45
Upgrade
Debt / EBITDA Ratio
5.078.14--2.893.78
Upgrade
Debt / FCF Ratio
9.1839.27-99.8211.912.24
Upgrade
Asset Turnover
0.520.480.310.460.430.40
Upgrade
Inventory Turnover
1.571.461.211.851.641.61
Upgrade
Quick Ratio
0.460.430.250.651.271.19
Upgrade
Current Ratio
1.111.070.521.031.791.65
Upgrade
Return on Equity (ROE)
11.21%14.52%-111.89%-17.90%6.14%5.75%
Upgrade
Return on Assets (ROA)
2.90%0.99%-21.74%-6.46%2.86%2.65%
Upgrade
Return on Capital (ROIC)
4.48%1.52%-33.20%-9.23%3.95%3.60%
Upgrade
Return on Capital Employed (ROCE)
7.40%2.60%--5.80%5.30%
Upgrade
Earnings Yield
3.18%8.16%-199.19%-23.15%11.75%7.34%
Upgrade
FCF Yield
5.66%2.76%-159.79%1.08%4.98%16.92%
Upgrade
Dividend Yield
---2.48%2.26%1.35%
Upgrade
Payout Ratio
0.02%0.01%--19.72%19.78%
Upgrade
Total Shareholder Return
---2.48%2.26%1.35%
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.